ENDO PHARMACEUTICALS SOLUTIONS INC.
Share on:
| Name: | ENDO PHARMACEUTICALS SOLUTIONS INC. |
| Jurisdiction: | New York |
| Legal type: | FOREIGN BUSINESS CORPORATION |
| Status: | Active |
| Date of registration: | 20 May 2010 (15 years ago) |
| Entity Number: | 3952090 |
| ZIP code: | 10005 |
| County: | New York |
| Place of Formation: | Delaware |
| Address: | 28 LIBERTY ST., NEW YORK, NY, United States, 10005 |
| Principal Address: | 1400 ATWATER DRIVE, MALVERN, PA, United States, 19355 |
| Name | Role | Address |
|---|---|---|
| C T CORPORATION SYSTEM | Agent | 28 LIBERTY ST., NEW YORK, NY, 10005 |
| Name | Role | Address |
|---|---|---|
| ENDO PHARMACEUTICALS SOLUTIONS INC. | DOS Process Agent | 28 LIBERTY ST., NEW YORK, NY, United States, 10005 |
| Name | Role | Address |
|---|---|---|
| BLAISE A. COLEMAN | Chief Executive Officer | 1400 ATWATER DRIVE, MALVERN, PA, United States, 19355 |
| Start date | End date | Type | Value |
|---|---|---|---|
| 2024-07-03 | 2024-07-03 | Address | 1400 ATWATER DRIVE, MALVERN, PA, 19355, USA (Type of address: Chief Executive Officer) |
| 2020-05-14 | 2024-07-03 | Address | 1400 ATWATER DRIVE, MALVERN, PA, 19355, USA (Type of address: Chief Executive Officer) |
| 2020-05-14 | 2024-07-03 | Address | 28 LIBERTY ST., NEW YORK, NY, 10005, USA (Type of address: Service of Process) |
| 2019-01-28 | 2024-07-03 | Address | 28 LIBERTY ST., NEW YORK, NY, 10005, USA (Type of address: Registered Agent) |
| 2018-05-02 | 2020-05-14 | Address | 1400 ATWATER DRIVE, MALVERN, PA, 19355, USA (Type of address: Chief Executive Officer) |
| Filing Number | Date Filed | Type | Effective Date |
|---|---|---|---|
| 240703003486 | 2024-07-03 | BIENNIAL STATEMENT | 2024-07-03 |
| 220517003158 | 2022-05-17 | BIENNIAL STATEMENT | 2022-05-01 |
| 200514060021 | 2020-05-14 | BIENNIAL STATEMENT | 2020-05-01 |
| SR-54665 | 2019-01-28 | CERTIFICATE OF CHANGE (BY AGENT) | 2019-01-28 |
| 180502006713 | 2018-05-02 | BIENNIAL STATEMENT | 2018-05-01 |
This company hasn't received any reviews.
Date of last update: 27 Mar 2025
Sources: New York Secretary of State